Wet AMD and DME Drug Development Summit | Virtual Event | April 13-15, 2021
Evvnt Promotion / evvnt
Archivo
13.04.2021 - 15.04.2021Online
Time: 08:00 - 15:45
Temas de la conferencia The Wet AMD and DME Drug Development Summit comes at a critical juncture, as the research community progresses novel drug candidates targeting angiogenesis-driven disease, and a pandemic further exposes the treatment limitations for a global aging population.
The treatment landscape for Wet Age-Related Macular Degeneration (wet AMD) and Diabetic Macular Edema (DME) has dramatically changed since the first anti-VEGF therapies were approved for ocular neovascularization.
Speakers: Casey Kopczynski, Chief Scientific Officer, Aerie Pharmaceuticals, Kevin Peters, Chief Scientific and Medical Officer and Senior Vice President, Aerpio Therapeutics and more.